ParenteralDosed ingredient Cosmetic cross-reference

Pantothenic Acid

CAS 79-83-4

Pantothenic Acid (CAS 79-83-4) is a Phase 4 pharmaceutical compound with 1 bioactivity target and 220 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
1
SOURCE DrugCentral / FAERS
Adverse signals
220
SOURCE IUPHAR / PharmGKB
PubMed IDs
0
SOURCE ChEMBL 36 B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Pantothenic Acid
CAS Number
79-83-4
UNII
19F5HK2737
InChIKey
GHOKWGTUZJEAQD-ZETCQYMHSA-N
ChEMBL ID
CHEMBL1594
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
dosed ingredientnatural productparenteral
SOURCE ChEMBL 36 B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 4 (Approved)
Approved or marketed human pharmaceutical use is represented in the source phase field.
ChEMBL CHEMBL1594 | Small molecule
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →
SOURCE ChEMBL 36 activities + assays 1 bioactivity row

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

TargetActivity ValueAssaysOrganism
- IC50 19976.309999999998 nM 1 -
SOURCE DrugCentral 2023 / FAERS disproportionality 80 associations

Adverse Event Associations

DrugCentral / FAERS disproportionality signal rows matched to this compound.

Reaction PTDrug AE LLRMedDRA
Contraindicated product administered 6 157.791 10078504
Off label use 388 156.648 10053762
Completed suicide 7 136.338 10010144
Product dose omission issue 537 136.183 10084406
Treatment failure 16 130.121 10066901
Diarrhoea 1240 126.69 10012735
Product use in unapproved indication 39 118.177 10076476
Muscle spasms 382 114.852 10028334
Synovitis 9 114.611 10042868
Toxicity to various agents 96 108.263 10070863
Systemic lupus erythematosus 17 106.339 10042945
Product use issue 42 104.433 10076309
Drug abuse 3 101.708 10013654
Infusion related reaction 57 93.64 10051792
Full blood count decreased 128 92.713 10017413
Fall 704 91.391 10016173
Fatigue 1304 89.538 10016256
Glossodynia 16 88.491 10018388
Drug ineffective 670 87.652 10013709
Plasma cell myeloma 173 87.232 10035226
Intentional product use issue 27 83.194 10076308
Maternal exposure during pregnancy 32 80.464 10071408
Fractional exhaled nitric oxide increased 30 76.005 10078429
Psoriasis 215 70.471 10037153
Therapy cessation 120 70.209 10065154
Asthenia 693 68.997 10003549
Drug interaction 136 66.739 10013710
Drug intolerance 105 66.147 10061822
Unevaluable event 162 65.029 10062355
Pericarditis 16 61.289 10034484
Device expulsion 93 60.885 10012578
Laboratory test abnormal 112 60.864 10023547
Intentional overdose 7 58.876 10022523
Dizziness 694 58.208 10013573
Memory impairment 220 54.06 10027175
General physical health deterioration 90 53.105 10049438
Duodenal ulcer perforation 4 52.693 10013849
Flatulence 117 51.689 10016766
Wound 36 50.268 10052428
Arthropathy 72 50.23 10003285
Neuropathy peripheral 271 49.87 10029331
Helicobacter infection 7 49.457 10054263
Hypoaesthesia 297 49.279 10020937
Overdose 49 48.137 10033295
Constipation 420 47.589 10010774
Lower respiratory tract infection 30 47.472 10024968
Myoglobin blood increased 33 46.848 10028625
Brain natriuretic peptide increased 47 46.837 10053405
Sensation of foreign body 41 46.421 10061549
Pneumonia 804 45.932 10035664

Association rows are source-linked signal records, not incidence rates or clinical causality claims.

SOURCE RxNorm drug names 2 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

NameRxCUI TypeSource
PANTOTHENIC ACID 7891 SU MTHSPL
pantothenic acid 7891 IN RXNORM
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Pantothenic Acid used for in pharmaceutical contexts?

Pantothenic Acid (CAS 79-83-4) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Pantothenic Acid?

Pantothenic Acid has 220 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Contraindicated product administered, Off label use, Completed suicide, Product dose omission issue, Treatment failure. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Pantothenic Acid also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for PANTOTHENIC ACID with EU status "permitted".

What clinical phase is Pantothenic Acid in?

Pantothenic Acid is rendered with ChEMBL max phase 4 (approved).